No Data
Express News | Harbin Pharmaceutical Group has been on a two-day trading limit: the current production and operation status is normal, and there have not been significant changes in the internal and external operating environment.
Express News | Harbin Pharmaceutical Group: There is no significant information that should have been disclosed but was not.
Express News | The continuous board pool: Guangdong Shunna Electric has 7 consecutive boards, Anyuan Coal Industry Group has 6 boards in 7 days.
Report for the third quarter of 2024 of Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group (600664.SH): net income of 0.508 billion yuan in the first three quarters, a year-on-year increase of 74.97%.
Gelonghui, October 25th - Harbin Pharmaceutical Group (600664.SH) announced its third-quarter report, with revenue for the first three quarters at 12.256 billion yuan, a year-on-year increase of 6.63%, net income of 0.508 billion yuan, a year-on-year increase of 74.97%, non-GAAP net income of 0.47 billion yuan, a year-on-year increase of 91.39%, and basic earnings per share of 0.20 yuan.
Harbin Pharmaceutical Group (600664.SH) released its performance for the first three quarters, with a net income of 0.508 billion yuan, a year-on-year increase of 74.97%.
Harbin Pharmaceutical Group (600664.SH) released the quarterly report for the first three quarters of 2024, during the reporting period the company achieved revenue...
No Data
